New Study: Experimental Cancer Vaccine Shows Promise In Animal Trials
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), have reported that an experimental therapeutic cancer vaccine induced two distinct and advantageous immune system responses that resulted in significant tumour regression in mice. Read more on Dynamite News: